Food and Drug Administration (The FDA) Limited this Thursday, May 5, 2022, d Use Of Single dose vaccine Against Covid-19 From Johnson & Johnson Inside America After reviewing the risks Blood clots Rare but Serious.
In a statement, d Federal agency Mentioned that Approval Emergency serum from J&J Will now limit those over 18 years of age For those for whom no other vaccine is available or medically appropriate, or for those who do not want to take any other vaccine.
Because of the risk of change Increase A kind Frozen Rare and dangerous, it is said Thrombosis With Thrombocytopenia syndrome (TTS), after vaccine administration.
“We are closely monitoring the presence of TTS after vaccination and using updated information from our security services to review emergency approvals,” said Dr. Peter Marks, director of the Center for Biological Evaluation and Research of the FDA. .
According to official data, approx 18 million doses The J&J vaccine has been administered in the United States, accounting for almost 7.7% of citizens Those in the country are considered to be fully vaccinated.
The FDA has commented, but its rarity Dangerous condition3.23 cases and nine cases per million doses of vaccine Death Sure
In December 2021, Authority Sanitary The United States has already recommended the use of Pfizer / BioNRech and Moderna vaccines over Johnson & Johnson.
United States, country Beatings The Kovid-19 epidemic has killed nearly a million people 66% Of the population vaccinated with complete rules.